Cargando…
Identification of CCNB2 as A Potential Non-Invasive Breast Cancer Biomarker in Peripheral Blood Mononuclear Cells Using The Systems Biology Approach
OBJECTIVE: Breast cancer (BC) still remains an imperative clinical issue, despite advances in the diagnosis, prognosis and treatment modalities of this malignancy. Hence, progress has been made to identify non-invasive, high sensitive and specific biomarkers. Since immune system affects development...
Autores principales: | Moradpoor, Raheleh, Zali, Hakimeh, Gharebaghian, Ahmad, Akbari, Mohammad Esmaeil, Ajdari, Soheila, Salimi, Mona |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Royan Institute
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8405074/ https://www.ncbi.nlm.nih.gov/pubmed/34455715 http://dx.doi.org/10.22074/cellj.2021.7053 |
Ejemplares similares
-
Identification and Validation of Stage-Associated PBMC Biomarkers in Breast Cancer Using MS-Based Proteomics
por: Moradpoor, Raheleh, et al.
Publicado: (2020) -
Crosstalk between Tumor Cells and Immune System Leads to Epithelial-Mesenchymal Transition Induction and Breast Cancer Progression
por: Moradpoor, Raheleh, et al.
Publicado: (2021) -
CDK1, CCNB1, and CCNB2 are Prognostic Biomarkers and Correlated with Immune Infiltration in Hepatocellular Carcinoma
por: Zou, Yiping, et al.
Publicado: (2020) -
Biological and clinical review of IORT-induced wound fluid in breast cancer patients
por: Jeibouei, Shabnam, et al.
Publicado: (2022) -
CCNB1 and CCNB2 involvement in the pathogenesis of psoriasis: a
bioinformatics study
por: Li, An-hai, et al.
Publicado: (2022)